newsfilter
← Latest News
Business Wire·

Evommune Announces $125 Million Private Placement

Evommune, Inc. ("Evommune" or the "Company") (NYSE:EVMN), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that it has